We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

42 hedge funds and large institutions have $3.09M invested in TherapeuticsMD in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more call options, than puts

Call options by funds: $14K | Put options by funds: $2K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 41 → 42 (+1)

2% more capital invested

Capital invested by funds: $3.03M → $3.09M (+$58.1K)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

1.7% less ownership

Funds ownership: 30.61% → 28.9% (-1.7%)

Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
7
Closed
4
Calls
$14K
Puts
$2K
Net Calls
+$12K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$13.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.16K
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.6K
4
Osaic Holdings
Osaic Holdings
Arizona
+$827
5
TRCT
Tower Research Capital (TRC)
New York
+$723

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$145K
2
TC
Tejara Capital
United Kingdom
-$49.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.62K
4
UBS Group
UBS Group
Switzerland
-$1.83K
5
Morgan Stanley
Morgan Stanley
New York
-$1.17K
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
26
Huntington National Bank
Ohio
$111 – – –
Wells Fargo
27
Wells Fargo
California
$53 -$40 -40 -41%
AWM
28
Activest Wealth Management
Florida
$37 – – –
SPIA
29
Steward Partners Investment Advisory
New York
$32 +$35 +35 New
FFA
30
Farther Finance Advisors
California
$29 +$30 +30 New
IA
31
IFP Advisors
Florida
$19 -$59 -59 -74%
PWA
32
Provenance Wealth Advisors
Florida
$19 – – –
TC
33
Truvestments Capital
Florida
$9 +$10 +10 New
HI
34
Harbour Investments
Wisconsin
$7 – – –
AssetMark Inc
35
AssetMark Inc
California
$4 – – –
NA
36
NewEdge Advisors
Louisiana
$3 – – –
GWMI
37
Guardian Wealth Management (Illinois)
Illinois
$2 – – –
EWA
38
EverSource Wealth Advisors
Alabama
$1 – – –
SWIM
39
Smallwood Wealth Investment Management
New Jersey
$1 +$2 +2 New
Citadel Advisors
40
Citadel Advisors
Florida
– -$145K -145,802 Closed
Group One Trading
41
Group One Trading
Illinois
– -$976 -1,135 Closed
FA
42
Fedenia Advisers
Wisconsin
– -$34 -40 Closed
Northwestern Mutual Wealth Management
43
Northwestern Mutual Wealth Management
Wisconsin
– -$2 -2 Closed
Simplex Trading
44
Simplex Trading
Illinois
– +$187 +188 +418%
1
2

TXMD Hedge Fund Activity: Q1 2025 in Review

42 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2025, worth a combined $3.09M — up 1.9% from $3.03M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TXMD positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $13.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $145K sold.

  • 42 institutional investors held TherapeuticsMD (TXMD) as of Q1 2025, up from 41 in Q4 2024.
  • Funds reported $3.09M of TherapeuticsMD stock for Q1 2025, up 1.9% quarter-over-quarter.
  • 5 funds opened new TherapeuticsMD positions in Q1 2025 and 4 closed out, a net change of +1 holder.
  • The largest TherapeuticsMD buyer in Q1 2025 was Two Sigma Securities, an estimated $13.1K added.
  • The largest TherapeuticsMD seller in Q1 2025 was Citadel Advisors, an estimated $145K sold.

Based on aggregated 13F filings for Q1 2025.